Physician profile
Ankur Narain
NPI 1023408242
$17,755.45
in general payments reported to CMS, 2019-2025
12 companies · $15K in 2025
The $15K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,898 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $3,240 · Food and Beverage: $3,016 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $3,239.79 |
| Food and Beverage | $3,015.66 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,720.40 | 2025 | |
| Stryker Corporation | $3,008.77 | 2024-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform+ |
| Encore Medical, Lp | $2,838.62 | 2024-2025 | Djo Surgical |
| Coastal Medical Technologies LLC | $782.32 | 2024-2025 | |
| Medacta USA, INC. | $148.36 | 2024 | |
| Zimmer Biomet Holdings, INC. | $96.67 | 2025 | Comprehensive Shoulder System |
| Baxter Healthcare | $46.17 | 2024 | Floseal |
| Pacira Pharmaceuticals Incorporated | $38.85 | 2024-2025 | Exparel, Iovera |
| Medtronic, INC. | $23.18 | 2024 | Aquamantys(Tm) |
| Sanara Medtech INC. | $19.82 | 2024 | Biasurge |
| Orthofix Medical, INC. | $16.56 | 2024 | Physio-Stim |
| Powerlink Ai, INC. | $15.73 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Narain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.